查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1764704

立體定位神經導航系統市場 - 全球及區域分析：按產品、應用、最終用戶及區域 - 分析與預測（2025-2035 年）

Stereotactic Neuro-Navigation System Market - A Global and Regional Analysis: Focus on Product, Application, End User, and Region - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 126 Pages | 商品交期: 1-5個工作天內

價格

預計 2024 年全球立體定位神經導航系統市場規模將達 8.407 億美元。

預計到 2035 年市場規模將激增至 31.03 億美元， 年複合成長率至 2035 年期間複合年成長率將達到 12.92%，呈現顯著成長。

主要市場統計數據
預測期 2025-2035
2025年評估 9.201億美元
2035年的預測 31.3億美元
複合年成長率 12.92%

受神經系統疾病盛行率上升、導航輔助手術優於傳統手術以及轉變為微創手術的推動，市場持續以兩位數的速度成長。

包括人工智慧 (AI)、機器學習 (ML) 和擴增實境(AR) 的整合在內的技術進步正在提高手術精度並擴展這些系統的功能。此外，微創手術 (MIS) 的日益普及也推動了對更先進、更精確的導航工具的需求。由於人口老化，需要手術治療的與老齡化相關的神經系統疾病的增加也推動了市場的發展。然而，這些系統的高價格、整合的複雜性以及手術期間的潛在併發症等挑戰可能會阻礙市場的成長。儘管存在這些挑戰，但持續的技術創新、有利的監管支援以及神經外科和其他專業的日益成長的應用預計將刺激市場的持續擴張。

市場介紹

立體定位神經導航系統市場正在快速發展，這得益於技術創新和策略聯盟的推動，這些聯盟旨在提高手術精度和患者治療效果。美敦力與Brainlab等合作夥伴關係率先推出了整合式導航解決方案，該解決方案將即時影像處理與先進的手術計劃相結合，以提高神經外科手術的精度。同時，像Orthofix Medical這樣的公司正在透過開發神經導航系統來擴展其產品組合，以促進微創脊椎手術。最近推出的產品，包括史賽克的顱腦導航系統，提供了增強的可視化和擴增實境功能，以支援複雜的腫瘤切除術。此外，Brainlab收購Novalis Circle等收購整合了專業知識和技術，有望推動市場強勁成長。這些發展支撐了對高精度神經外科手術工具日益成長的需求，推動了該領域的創新和臨床應用的成長。

對產業的影響

全球立體定位神經導航系統市場由美敦力、Brainlab、Stryker和Orthofix Medical Inc.等領導企業主導。透過將即時導航與MRI和CT等先進影像技術相結合，這些公司為腫瘤切除、深部腦部刺激和癲癇治療等精準腦外科手術提供全面的解決方案。美敦力的StealthStation和Brainlab的Curve導航系統等產品體現了這種技術整合，提高了手術精度並降低了手術風險。該行業的影響涵蓋臨床神經外科、研究和培訓，促進了微創手術並改善了患者預後。透過持續的技術創新和不斷拓展的臨床應用，立體定位神經導航市場正在顯著推動全球神經外科治療的發展。

市場區隔

細分 1：按產品

  • 神經導航系統
  • 立體定位框架單元

從產品角度來看，全球立體定位神經導航系統市場將由神經導航系統驅動，到2024年將佔據80.9%的市場。該領域佔據市場主導地位的關鍵原因是其技術力、準確性提升以及在現代外科手術中日益增強的多功能性。神經導航系統利用即時3D成像以及與MRI、 電腦斷層掃描和超音波等先進技術的整合，在手術過程中提供精準的動態引導。這使得其在定位和導航大腦和脊髓複雜區域方面擁有卓越的精確度，這對於最大限度地減少併發症和改善患者預後至關重要。

細分2：按應用

  • 顱骨
  • 脊髓

從應用類型來看，全球立體定位神經導航系統市場主要由脊椎領域驅動，2024 年佔 62.6%。由於退化性疾病、脊椎畸形和創傷等脊椎疾病發生率高，需要頻繁的外科手術干預，因此脊椎應用在神經導航系統市場中佔據主導地位。微創脊椎手術 (MISS) 的日益普及進一步刺激了市場需求，因為這些手術需要神經導航系統提供的高精度支援。此外，脊椎手術的複雜性以及日益成長的老化人口面臨與老齡化相關的脊椎問題，也促使脊椎導航系統的使用率不斷上升。這些因素共同推動脊椎應用在市場中超越顱腦應用。

細分 3：按最終用戶

  • 醫院
  • 麻醉學

按最終用戶分類，全球立體定位神經導航系統市場由醫院部門推動，2024 年的佔有率為 91.9%。醫院在最終用戶的神經導航系統市場中佔據主導地位，因為它們在提供全面的外科護理方面發揮著核心作用，並且能夠處理複雜和大批量的手術。醫療保健機構，尤其是學術醫療中心和大型醫療機構，配備了先進的基礎設施、熟練的醫療專業人員以及神經外科、整形外科和脊椎外科等專科部門，這推動了對神經導航系統的需求。這些系統對於執行精確和微創手術至關重要，從而改善患者的預後並縮短復原時間。此外，醫院通常執行更多的手術，從常規手術到複雜手術，這進一步增強了它們的市場主導地位。醫院投資最尖端科技和採用導航系統多學科應用的能力使其成為該市場成長的關鍵參與者。

細分4：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 其他
  • 其他地區

預計北美地區的立體定位神經導航系統市場在預測期內將達到12.36%的顯著成長率。這一顯著成長得益於幾個關鍵因素，包括先進的醫療基礎設施、創新技術的高採用率以及強大的研發能力。該地區擁有一些世界領先的醫院、醫療中心和學術機構，擁有最先進的設備和高技能的專業人員。這些基礎設施促進了神經導航系統等最尖端科技的採用。此外，北美脊椎和顱腦疾病的發生率很高，這增加了對精準外科手術的需求。該地區的醫療保健系統提供了廣泛的先進治療途徑，從而促進了微創手術的應用，而神經導航在這些手術中至關重要。此外，美國和加拿大擁有完善的法規環境和對技術創新的大力支持，Medtronic和史賽克等公司主導神經導航技術的開發，進一步鞏固了北美在該市場的領先地位。

立體定位神經導航系統市場的最新趨勢

  • 2024年9月，史賽克公司收購了NICO公司，非上市公司，致力於為腫瘤和腦出血(ICH)手術提供系統性微創手術。此次收購增強了史賽克對神經技術領域的投入，尤其是在腫瘤和中風治療領域。
  • 2024 年 5 月，AiM Robotics 與 Synaptive Medical 合作，將其神經導航軟體 Modus Nav 整合到神經外科機器人中，以改善視覺化、導航和控制。
  • 2023年7月，史賽克公司推出了搭載顱腦引導軟體的Q引導系統。

需求——促進因素、挑戰、機會

市場促進因素：

  • 神經系統疾病盛行率上升：神經系統疾病盛行率上升是立體定位神經導航市場的主要驅動力。隨著腦腫瘤、癲癇和巴金森氏症等疾病的全球發生率上升，對精準外科手術的需求也隨之增加。例如，根據健康數據 (Health Data) 的數據，到 2021 年，約有 34 億人將患有影響神經系統的疾病。立體定位神經導航系統具有高精度和微創性，正擴大被用於應對這些挑戰。此外，神經系統疾病是全球疾病負擔的首要原因。此外，全球人口正在老化，導致與老齡化相關的神經系統疾病增加。這些人口結構變化導致對神經外科手術的需求增加，進而對先進的神經導航技術的需求也隨之增加。隨著全球人口老化，與老齡化相關的神經系統疾病（如失智症和帕金森氏症）的發生率也在上升。這導致需要手術干預治療這些疾病的患者數量增加。隨著對外科治療的需求增加，對指導這些複雜手術的準確可靠的神經導航系統的需求也在增加。

市場挑戰：

  • 與使用導航系統相關的併發症：神經導航系統透過提高精確度、安全性和效率徹底改變了神經外科手術，但其使用並非沒有併發症。與任何先進技術一樣，導航系統在神經外科手術中的整合也面臨挑戰。在導航輔助神經外科手術中，器械的進入點和軌跡都定義明確，但由於手動攻絲和插入，在螺絲插入過程中可能會出現不準確，導致軸向擺動和最大徑向偏移。為了緩解這種情況，最好將螺絲插入延遲到所有計劃的軌跡都完成之後。現在可以使用動力椎弓根螺釘驅動系統，透過提供更快、更準確的螺釘插入來改善外科醫生的體驗。

市場機會：

  • 人工智慧 (AI) 與機器學習的融合：人工智慧 (AI) 和機器學習 (ML) 技術為神經外科的整合提供了巨大的機會和變革能力。這些技術在多個關鍵應用中發揮關鍵作用，例如透過分割術中影像來增強導航系統，尤其是在精確放置椎弓根螺釘方面。此外，ML 演算法在解釋椎間盤影像和全脊椎X光相片方面發揮關鍵作用，有助於實現臨床醫生診斷程序的自動化和簡化。此外，虛擬實境 (VR) 和擴增實境(AR) 系統與外科培訓計畫的整合已經顯示出良好的效果。這些先進技術為受訓人員提供了身臨其境型學習體驗，使他們能夠在逼真的虛擬環境中模擬外科手術過程。研究表明，這種身臨其境型訓練與縮短手術時間和提高受訓人員整體表現有關，凸顯了 VR 和 AR 在加強外科教育和提高熟練程度方面的價值。

產品/創新策略：全球立體定位神經導航系統市場已根據產品應用領域、最終用戶、地區等不同類別進行廣泛細分。這有助於讀者清楚了解哪個細分市場佔有最大佔有率以及哪個細分市場在未來幾年可能會成長。

成長/行銷策略：夥伴關係、聯盟和共同開發佔主要發展的大部分，即 2020 年 1 月至 2025 年 4 月全球立體定向神經導航系統市場的發展佔總量的近 35.0%。

競爭策略：全球立體定位神經導航系統市場現有眾多參與者及其產品系列。本研究分析並概述了全球立體定位神經導航系統市場中的主要企業概況，包括現有提供立體定位神經導航系統產品的公司。

目錄

執行摘要

第1章市場：產業展望

  • 市場趨勢
  • 贖回方案
  • 專利分析
  • 監管狀況/合規性
  • 供應鏈分析
  • 定價分析
  • 市場動態

2. 全球立體定位神經導航系統市場（按產品），百萬美元，2023-2035 年

  • 神經導航系統
    • 隱形站導航
    • 曲線導航
    • Q導引系統
    • 簡易導航
    • 7D手術系統
    • Xvision-Spine 系統
    • 卡杜塞斯 S (AR)
  • 立體定位框架單元

3. 全球立體定位神經導航系統市場（按應用），百萬美元，2023-2035 年

  • 脊椎
  • 顱骨

4. 全球立體定位神經導航系統市場（按最終用戶分類），百萬美元，2023 年至 2035 年

  • 醫院、診所
  • 門診手術中心（ASC）

5. 全球立體定位神經導航系統市場（按地區分類），百萬美元，2023-2035 年

  • 北美洲
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 美國
    • 加拿大
  • 歐洲
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 英國
    • 德國
    • 法國
    • 其他
  • 亞太地區
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 日本
    • 中國
    • 其他
  • 其他地區
    • 區域概況
    • 市場成長動力
    • 成長抑制因素

6. 市場競爭基準化分析與公司概況

  • 關鍵策略和發展
  • 產品基準
  • 市場佔有率
  • 公司簡介
    • Medtronic Plc
    • Brainlab AG
    • ClearPoint Neuro, Inc.
    • Elekta
    • Stryker Corporation
    • Orthofix Medical Inc
    • SaphireX Surgicals
    • FHC
    • Integra LifeSciences Corporation
    • SURGLASSES Inc.
    • HRS Navigation
    • Augmedics

第7章調查方法

Product Code: BHR3045SA

This report can be delivered within 1 working day.

Introduction of Stereotactic Neuro-Navigation System Market

The global stereotactic neuro-navigation system market, initially valued at $840.7 million in 2024, is projected to witness substantial growth, surging to $3,100.3 million by 2035, marking a remarkable compound annual growth rate (CAGR) of 12.92% over the period from 2025 to 2035.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$920.1 Million
2035 Forecast$3,100.3 Million
CAGR12.92%

The market has been witnessing double-digit growth, driven by the rising prevalence of neurological disorders, benefits offered by navigation-assisted surgeries over conventional surgeries, and a shift toward minimally invasive surgery.

Technological advancements, including the integration of artificial intelligence (AI), machine learning (ML), and augmented reality (AR), have been enhancing surgical precision and expanding the capabilities of these systems. Additionally, the increasing adoption of minimally invasive surgery (MIS) has been driving the demand for more advanced and accurate navigation tools. The market is also bolstered by a growing aging population, leading to an increase in age-related neurological conditions that require surgical treatment. However, challenges such as the high cost of these systems, integration complexities, and potential complications during surgery may hinder market growth. Despite these challenges, ongoing innovation, favorable regulatory support, and expanding applications in neurosurgery and other specialties are expected to fuel continued market expansion.

Market Introduction

The stereotactic neuro-navigation system market has been rapidly advancing, driven by technological innovations and strategic collaborations that enhance surgical precision and patient outcomes. Partnerships, such as Medtronic's collaboration with Brainlab, have been pioneering integrated navigation solutions that combine real-time imaging with advanced surgical planning, thereby improving accuracy in neurosurgical procedures. Meanwhile, companies such as Orthofix Medical have been expanding their portfolio through the development of neuro-navigation system, facilitating minimally invasive spine surgeries. Recent product launches, including Stryker's Cranial Navigation System, offer enhanced visualization and augmented reality features that support complex tumor resections. Additionally, acquisitions such as Brainlab's acquisition of Novalis Circle are consolidating expertise and technology, positioning the market for robust growth. These developments underscore the increasing demand for precision neurosurgery tools, driving innovation and expanding clinical applications in the field.

Industrial Impact

The global stereotactic neuro-navigation system market, driven by industry leaders such as Medtronic, Brainlab, Stryker, and Orthofix Medical Inc., has been transforming the landscape of neurosurgical interventions. By integrating advanced imaging modalities such as MRI and CT with real-time navigation, these companies provide comprehensive solutions for precise brain surgeries, including tumor resections, deep brain stimulation, and epilepsy treatment. Products such as Medtronic's StealthStation and Brainlab's Curve Navigation System exemplify this technological integration, enhancing surgical accuracy and reducing operative risks. The industrial impact extends across clinical neurosurgery, research, and training, facilitating minimally invasive procedures and improving patient outcomes. Through continuous innovation and expanding clinical applications, the stereotactic neuro-navigation market has been driving significant advancements in neurosurgical care globally.

Market Segmentation:

Segmentation 1: by Product

  • Neuro-Navigation System
  • Stereotactic Frame Units

Neuro-Navigation Systems Segment to Dominate the Stereotactic Neuro-Navigation System Market (by Product)

Based on product, the global stereotactic neuro-navigation system market was led by the neuro-navigation system, which held an 80.9% share in 2024. The segment dominates the market primarily due to its advanced technological capabilities, enhanced precision, and increased versatility in modern surgical practices. Neuro-navigation systems utilize real-time 3D imaging and advanced integration with modalities such as MRI, CT scans, and ultrasound to provide precise, dynamic guidance during surgery. This offers superior accuracy in targeting and navigating complex areas of the brain and spinal cord, which is essential for minimizing complications and improving patient outcomes.

Segmentation 2: by Application

  • Cranial
  • Spinal

Spinal Segment to Dominate the Stereotactic Neuro-Navigation System Market (by Application)

Based on application type, the global stereotactic neuro-navigation system market was led by the spinal segment, which held a 62.6% share in 2024. Spinal applications dominate the neuro-navigation system market due to the higher incidence of spinal conditions, such as degenerative diseases, spinal deformities, and trauma, which require frequent surgical intervention. The increasing adoption of minimally invasive spine surgery (MISS) further drives demand, as these procedures require enhanced precision, which neuro-navigation systems provide. Additionally, the complexity of spinal surgeries, combined with the growing aging population facing age-related spinal issues, contributes to the greater utilization of spinal navigation systems. These factors collectively make spinal applications the leading segment in the market over cranial applications.

Segmentation 3: by End User

  • Hospitals
  • ASCs

Hospital Segment to Dominate the Stereotactic Neuro-Navigation System Market (by End User)

Based on end user, the global stereotactic neuro-navigation system market was led by the hospital segment, which held a 91.9% share in 2024. Hospitals dominate the neuro-navigation system market based on end-users due to their central role in providing comprehensive surgical care and their capacity to handle complex and high-volume surgeries. Hospitals, especially academic medical centers, and large healthcare facilities, are equipped with advanced infrastructure, skilled medical professionals, and specialized departments such as neurosurgery, orthopedics, and spinal surgery, which drive the demand for neuro-navigation systems. These systems are essential for performing precise, minimally invasive surgeries, thereby improving patient outcomes and reducing recovery times, all of which are crucial for hospitals striving to deliver the best care. Additionally, hospitals generally conduct a higher volume of surgeries, ranging from routine to complex procedures, which further contributes to their market dominance. The ability of hospitals to invest in cutting-edge technology and adopt multi-specialty applications of navigation systems makes them key players in the growth of this market.

Segmentation 4: by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest-of-Europe
  • Asia-Pacific
    • Japan
    • China
    • Rest-of-Asia-Pacific
  • Rest-of-the-World

The stereotactic neuro-navigation system market in the North America region is expected to witness a significant growth rate of 12.36% during the forecast period. This notable growth can be attributed to several key factors, including advanced healthcare infrastructure, high adoption of innovative technologies, and strong research and development capabilities. The region is home to some of the world's leading hospitals, medical centers, and academic institutions, which are equipped with state-of-the-art facilities and highly skilled professionals. This infrastructure facilitates the adoption of cutting-edge technologies such as neuro-navigation systems. Additionally, North America has a high prevalence of spinal and cranial conditions, which increases the demand for precise surgical interventions. The region's healthcare system, which provides wide access to advanced treatments, drives the use of minimally invasive surgeries where neuro-navigation is essential. Furthermore, the U.S. and Canada have robust regulatory environments and strong support for innovation, with companies such as Medtronic and Stryker leading the development of neuro-navigation technologies, thereby further cementing North America's leadership in this market.

Recent Developments in the Stereotactic Neuro-Navigation System Market

  • In September 2024, Stryker Corporation acquired NICO Corporation, a privately held firm offering a systematic approach to minimally invasive surgery for tumor and intracerebral hemorrhage (ICH) procedures. This acquisition reinforces Stryker's commitment to neurotechnology, particularly in tumor and stroke care.
  • In May 2024, AiM Robotics partnered with Synaptive Medical to integrate the Modus Nav neuro-navigation software into its neurosurgery robot, improving visualization, navigation, and control.
  • In July 2023, Stryker Corporation launched the Q Guidance System with Cranial Guidance Software.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

  • Rising Prevalence of Neurological Disorder: The rising prevalence of neurological disorders is a significant driver of the stereotactic neuro-navigation market. As the global incidence of conditions such as brain tumors, epilepsy, and Parkinson's disease increases, the demand for precise surgical interventions has escalated. For instance, as per the Health Data, around 3.40 billion individuals had conditions affecting the nervous system in 2021. Stereotactic neuro-navigation systems, which offer high accuracy and minimal invasiveness, are increasingly utilized to address these challenges. Moreover, neurological conditions are the number one leading cause of disease burden worldwide. Moreover, the global population has been aging, leading to an increase in age-related neurological conditions. This demographic shift is contributing to a higher demand for neurosurgical interventions and, consequently, for advanced neuro-navigation technologies. As the global population ages, the incidence of age-related neurological diseases, such as dementia and Parkinson's disease, rises. This contributes to a larger patient base requiring surgical intervention for these conditions. As the demand for surgical treatments increases, so does the demand for accurate, reliable neuro-navigation systems to guide these complex procedures.

Market Challenges:

  • Complications Associated with the Use of Navigation Systems: While neuro-navigation systems have revolutionized neurosurgery by enhancing precision, safety, and efficiency, their use does not come without complications. Like any advanced technology, the integration of navigation systems in neurosurgery has its challenges. In navigation-assisted neuro surgeries, while entry points and trajectories for instrumentation are clearly defined, inaccuracies may arise during screw insertion due to manual tapping or insertion, leading to wobbling and maximal radial movement from the center of the axis. To mitigate this, it is advisable to delay screw insertion until after all planned trajectories have been created. Presently, powered pedicle screw drive systems are available, offering faster and more accurate screw insertions, thereby enhancing the surgeon's experience.

Market Opportunities:

  • Integration of Artificial Intelligence (AI) and Machine Learning: AI and machine learning (ML) techniques present significant opportunities for integration within neurosurgery, offering transformative capabilities. These technologies are pivotal in several key applications, including the segmentation of intraoperative images to enhance navigation systems, especially in the precise placement of pedicle screws. Moreover, ML algorithms play a vital role in the interpretation of images depicting intervertebral discs or full spine radiographs, facilitating automation and streamlining diagnostic procedures for clinicians. Furthermore, the integration of virtual reality (VR) and augmented reality (AR) systems into surgical training programs has already shown promising outcomes. These advanced technologies provide immersive learning experiences for trainees, enabling them to simulate surgical procedures in realistic virtual environments. Studies have indicated that such immersive training correlates with improved operative times and overall performance among trainees, underscoring the value of VR and AR in enhancing surgical education and proficiency.

How can this report add value to an organization?

Product/Innovation Strategy: The global stereotactic neuro-navigation system market has been extensively segmented based on various categories, such as product application area, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Partnerships, alliances, and collaborations accounted for the maximum number of key developments, i.e., nearly 35.0% of the total developments in the global stereotactic neuro-navigation system market were between January 2020 and April 2025.

Competitive Strategy: The global stereotactic neuro-navigation system market has numerous established players with product portfolios. Key players in the global stereotactic neuro-navigation system market analyzed and profiled in the study include established players offering products for stereotactic neuro-navigation systems.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2024. A historical year analysis has been done for the period FY2020-FY2023. The market size has been estimated for FY2024 and projected for the period FY2025-FY2035.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report presents a comprehensive market study of the upstream and downstream products in the stereotactic neuro-navigation system market.
  • The market contribution of stereotactic neuro-navigation systems is anticipated to be launched in the future and has been calculated based on the historical analysis of the solutions.
  • Revenues of the companies have been referenced from their annual reports for FY2023 and FY2024. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The market has been mapped based on the available stereotactic neuro-navigation systems. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in stereotactic neuro-navigation systems, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Validation of the numbers of the different segments of the market in focus
  • Percentage split of individual markets for regional analysis

Secondary Research:

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles

Paid databases

The key data points taken from the secondary sources include:

  • Segmentations and percentage shares
  • Data for market value
  • Key industry trends of the top players of the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Medtronic Plc
  • Brainlab AG
  • ClearPoint Neuro, Inc.
  • Elekta
  • Stryker Corporation
  • Orthofix Medical Inc.
  • Saphirex Surgicals
  • FHC
  • Integra LifeSciences Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Trends
    • 1.1.1 Leveraging Synergies to Diversify Business Portfolio
  • 1.2 Reimbursement Scenario
  • 1.3 Patent Analysis
  • 1.4 Regulatory Landscape/Compliance
    • 1.4.1 U.S.
    • 1.4.2 Europe
      • 1.4.2.1 U.K.
    • 1.4.3 Japan
    • 1.4.4 China
    • 1.4.5 Rest-of-the-World (RoW)
  • 1.5 Supply Chain Analysis
  • 1.6 Pricing Analysis
  • 1.7 Market Dynamics
    • 1.7.1 Market Drivers
      • 1.7.1.1 Rising Prevalence of Neurological Disorders
      • 1.7.1.2 Benefits Offered by Navigation-Assisted Surgeries Over Conventional Surgeries
    • 1.7.2 Market Restraints
      • 1.7.2.1 Complications Associated with the Use of Navigation Systems
      • 1.7.2.2 High Cost of Acquisition
    • 1.7.3 Market Opportunities
      • 1.7.3.1 Integration of Artificial Intelligence (AI) and Machine Learning

2 Global Stereotactic Neuro-navigation System Market (By Product), $Million, 2023-2035

  • 2.1 Neuro-Navigation System
    • 2.1.1 Stealth Station Navigation
      • 2.1.1.1 Overview
      • 2.1.1.2 Installed Base
      • 2.1.1.3 Average Selling Price
      • 2.1.1.4 Unit Sold
      • 2.1.1.5 Market Sizing and Forecast
    • 2.1.2 Curve Navigation
      • 2.1.2.1 Overview
      • 2.1.2.2 Installed Base
      • 2.1.2.3 Average Selling Price
      • 2.1.2.4 Unit Sold
      • 2.1.2.5 Market Sizing and Forecast
    • 2.1.3 Q Guidance System
      • 2.1.3.1 Overview
      • 2.1.3.2 Installed Base
      • 2.1.3.3 Average Selling Price
      • 2.1.3.4 Unit Sold
      • 2.1.3.5 Market Sizing and Forecast
    • 2.1.4 easyNav
      • 2.1.4.1 Overview
      • 2.1.4.2 Installed Base
      • 2.1.4.3 Average Selling Price
      • 2.1.4.4 Unit Sold
      • 2.1.4.5 Market Sizing and Forecast
    • 2.1.5 7D Surgical System
      • 2.1.5.1 Overview
      • 2.1.5.2 Installed Base
      • 2.1.5.3 Average Selling Price
      • 2.1.5.4 Unit Sold
      • 2.1.5.5 Market Sizing and Forecast
    • 2.1.6 Xvision-Spine System
      • 2.1.6.1 Overview
      • 2.1.6.2 Installed Base
      • 2.1.6.3 Average Selling Price
      • 2.1.6.4 Unit Sold
      • 2.1.6.5 Market Sizing and Forecast
    • 2.1.7 Caduceus S (AR)
      • 2.1.7.1 Overview
      • 2.1.7.2 Average Selling Price
      • 2.1.7.3 Unit Sold
      • 2.1.7.4 Market Sizing and Forecast
  • 2.2 Stereotactic Frame Units

3 Global Stereotactic Neuro-navigation System Market (By Application), $Million, 2023-2035

  • 3.1 Spinal
  • 3.2 Cranial

4 Global Stereotactic Neuro-navigation System Market (By End User), $Million, 2023-2035

  • 4.1 Hospitals and Clinics
  • 4.2 Ambulatory Surgical Centers (ASCs)

5 Global Stereotactic Neuro-navigation System Market (By Region), $Million, 2023-2035

  • 5.1 North America
    • 5.1.1 Regional Overview
    • 5.1.2 Driving Factors for Market Growth
    • 5.1.3 Factors Challenging the Market
    • 5.1.4 U.S.
    • 5.1.5 Canada
  • 5.2 Europe
    • 5.2.1 Regional Overview
    • 5.2.2 Driving Factors for Market Growth
    • 5.2.3 Factors Challenging the Market
    • 5.2.4 U.K.
    • 5.2.5 Germany
    • 5.2.6 France
    • 5.2.7 Rest of the Europe
  • 5.3 Asia Pacific
    • 5.3.1 Regional Overview
    • 5.3.2 Driving Factors for Market Growth
    • 5.3.3 Factors Challenging the Market
    • 5.3.4 Japan
    • 5.3.5 China
    • 5.3.6 Rest-of-Asia-Pacific
  • 5.4 Rest-of-the-World
    • 5.4.1 Regional Overview
    • 5.4.2 Driving Factors for Market Growth
    • 5.4.3 Factors Challenging the Market

6 Markets - Competitive Benchmarking & Company Profiles

  • 6.1 Key Strategies and Development
  • 6.2 Product Benchmarking
  • 6.3 Market Share
  • 6.4 Company Profiles
    • 6.4.1 Medtronic Plc
      • 6.4.1.1 Overview
      • 6.4.1.2 Top Products/Product Portfolio
      • 6.4.1.3 Top Competitors
      • 6.4.1.4 Target Customers
      • 6.4.1.5 Key Personal
      • 6.4.1.6 Analyst View
    • 6.4.2 Brainlab AG
      • 6.4.2.1 Overview
      • 6.4.2.2 Top Products/Product Portfolio
      • 6.4.2.3 Top Competitors
      • 6.4.2.4 Target Customers
      • 6.4.2.5 Key Personal
      • 6.4.2.6 Analyst View
    • 6.4.3 ClearPoint Neuro, Inc.
      • 6.4.3.1 Overview
      • 6.4.3.2 Top Products/Product Portfolio
      • 6.4.3.3 Top Competitors
      • 6.4.3.4 Target Customers
      • 6.4.3.5 Key Personal
      • 6.4.3.6 Analyst View
    • 6.4.4 Elekta
      • 6.4.4.1 Overview
      • 6.4.4.2 Top Products/Product Portfolio
      • 6.4.4.3 Top Competitors
      • 6.4.4.4 Target Customers
      • 6.4.4.5 Key Personal
      • 6.4.4.6 Analyst View
    • 6.4.5 Stryker Corporation
      • 6.4.5.1 Overview
      • 6.4.5.2 Top Products/Product Portfolio
      • 6.4.5.3 Top Competitors
      • 6.4.5.4 Target Customers
      • 6.4.5.5 Key Personal
      • 6.4.5.6 Analyst View
    • 6.4.6 Orthofix Medical Inc
      • 6.4.6.1 Overview
      • 6.4.6.2 Top Products/Product Portfolio
      • 6.4.6.3 Top Competitors
      • 6.4.6.4 Target Customers
      • 6.4.6.5 Key Personal
      • 6.4.6.6 Analyst View
    • 6.4.7 SaphireX Surgicals
      • 6.4.7.1 Overview
      • 6.4.7.2 Top Products/Product Portfolio
      • 6.4.7.3 Top Competitors
      • 6.4.7.4 Target Customers
      • 6.4.7.5 Key Personal
      • 6.4.7.6 Analyst View
    • 6.4.8 FHC
      • 6.4.8.1 Overview
      • 6.4.8.2 Top Products/Product Portfolio
      • 6.4.8.3 Top Competitors
      • 6.4.8.4 Target Customers
      • 6.4.8.5 Key Personal
      • 6.4.8.6 Analyst View
    • 6.4.9 Integra LifeSciences Corporation
      • 6.4.9.1 Overview
      • 6.4.9.2 Top Products/Product Portfolio
      • 6.4.9.3 Top Competitors
      • 6.4.9.4 Target Customers
      • 6.4.9.5 Key Personal
      • 6.4.9.6 Analyst View
    • 6.4.10 SURGLASSES Inc.
      • 6.4.10.1 Overview
      • 6.4.10.2 Top Products/Product Portfolio
      • 6.4.10.3 Top Competitors
      • 6.4.10.4 Target Customers
      • 6.4.10.5 Key Personal
      • 6.4.10.6 Analyst View
    • 6.4.11 HRS Navigation
      • 6.4.11.1 Overview
      • 6.4.11.2 Top Products/Product Portfolio
      • 6.4.11.3 Top Competitors
      • 6.4.11.4 Target Customers
      • 6.4.11.5 Key Personal
      • 6.4.11.6 Analyst View
    • 6.4.12 Augmedics
      • 6.4.12.1 Overview
      • 6.4.12.2 Top Products/Product Portfolio
      • 6.4.12.3 Top Competitors
      • 6.4.12.4 Target Customers
      • 6.4.12.5 Key Personal
      • 6.4.12.6 Analyst View

7 Research Methodology

  • 7.1 Data Sources
    • 7.1.1 Primary Data Sources
    • 7.1.2 Secondary Data Sources
    • 7.1.3 Data Triangulation
  • 7.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Stereotactic Neuro-Navigation System Market (by Scenario), $Million, 2025, 2029, and 2035
  • Figure 2: Global Stereotactic Neuro-Navigation System Market, $Million, 2024 and 2035
  • Figure 3: Stereotactic Neuro-Navigation System Market (by Application), $Million, 2024, 2029, and 2035
  • Figure 4: Stereotactic Neuro-Navigation System Market (by End User), in Million, 2024, 2029, and 2035
  • Figure 5: Organization of the Health System in the U.S.
  • Figure 6: Number of Patents Filed, January 2021-April 2025
  • Figure 7: FDA Classification
  • Figure 8: EU Classification
  • Figure 9: NHS Classification
  • Figure 10: Japan Federation of Medical Devices Associations (JFMDA) Classification
  • Figure 11: NMPA Classification
  • Figure 12: Supply Chain and Risks within the Supply Chain
  • Figure 13: Prevalence of Parkinson's Disease (by Region), 2016-2021
  • Figure 14: Increasing Incidence of CNS Brain Tumor Cases (by Region), 2022, 2025, 2035, and 2045
  • Figure 15: Increasing Aging Population Globally, Million, 2020-2023
  • Figure 16: Global Stereotactic Neuro-Navigation System Market (by Product), $Million, 2024,2029, and 2035
  • Figure 17: Global Stereotactic Neuro-Navigation System Market, by Product, by Neuro-Navigation Systems, $Million, 2023-2035
  • Figure 18: Global Stereotactic Neuro-Navigation System Market, by Neuro-Navigation Systems, $Million, 2023-2035
  • Figure 19: Stealth Station Navigation System, Installed Base, 2023-2035
  • Figure 20: Stealth Station Navigation System, Unit Sold, 2023-2035
  • Figure 21: Global Stereotactic Neuro-Navigation System Market, Neuro-Navigation Systems, Stealth Station Navigation System, $Million, 2023-2035
  • Figure 22: Curve Navigation System, Installed Base, 2023-2035
  • Figure 23: Curve Navigation System, Unit Sold, 2023-2035
  • Figure 24: Global Stereotactic Neuro-Navigation System Market, by Neuro-Navigation Systems, Curve Navigation, $Million, 2023-2035
  • Figure 25: Q Guidance System, Installed Base, 2023-2035
  • Figure 26: Q Guidance System, Unit Sold, 2023-2035
  • Figure 27: Global Stereotactic Neuro-Navigation System Market, by Neuro-Navigation Systems, Q Guidance System $Million, 2023-2035
  • Figure 28: easyNav, Installed Base, 2023-2035
  • Figure 29: easyNav, Unit Sold, 2023-2035
  • Figure 30: Global Stereotactic Neuro-Navigation System Market, by Neuro-Navigation Systems, easyNav, $Million, 2023-2035
  • Figure 31: 7D Surgical System, Installed Base, 2023-2035
  • Figure 32: 7D Surgical System, Unit Sold, 2023-2035
  • Figure 33: Global Stereotactic Neuro-Navigation System Market, by Neuro-Navigation Systems, 7D Surgical System, $Million, 2023-2035
  • Figure 34: Xvision-Spine System, Installed Base, 2023-2035
  • Figure 35: Xvision-Spine System, Unit Sold, 2023-2035
  • Figure 36: Global Stereotactic Neuro-Navigation System Market, by Neuro-Navigation Systems, Xvision-Spine System, $Million, 2023-2035
  • Figure 37: Caduceus S (AR) System, Installed Base, 2023-2035
  • Figure 38: Caduceus S (AR), Unit Sold, 2023-2035
  • Figure 39: Global Stereotactic Neuro-Navigation System Market, by Neuro-Navigation Systems, Caduceus S (AR), $Million, 2023-2035
  • Figure 40: Global Stereotactic Neuro-Navigation System Market, Stereotactic Frame Units, $Million, 2023-2035
  • Figure 41: Global Stereotactic Neuro-Navigation System Market (by Application), $Million, 2023-2035
  • Figure 42: Global Stereotactic Neuro-Navigation System Market, Spinal, $Million, 2023-2035
  • Figure 43: Global Stereotactic Neuro-Navigation System Market, Cranial, $Million, 2023-2035
  • Figure 44: Global Stereotactic Neuro-Navigation System Market (by End User), $Million, 2023-2035
  • Figure 45: Global Stereotactic Neuro-Navigation System Market, Hospitals and Clinics, $Million, 2023-2035
  • Figure 46: Global Stereotactic Neuro-Navigation System Market, Ambulatory Surgical Centers, $Million, 2023-2035
  • Figure 47: North America Stereotactic Neuro-Navigation Market, Spinal Navigation Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 48: North America Stereotactic Neuro-Navigation Market, Cranial Stereotactic Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 49: North America Stereotactic Neuro-Navigation Market, $Million, 2023-2035
  • Figure 50: Incidences of Neurological Disorders in U.S., Million, 2018-2021
  • Figure 51: U.S. Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 52: Incidences of Neurological Disorders in Canada, Million, 2018-2021
  • Figure 53: Canada Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 54: Europe Stereotactic Neuro-Navigation Market, Spinal Navigation Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 55: Europe Stereotactic Neuro-Navigation Market, Cranial Stereotactic Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 56: Europe Stereotactic Neuro-Navigation Market, $Million, 2023-2035
  • Figure 57: Incidences of Neurological Disorders in U.K., Million, 2018-2021
  • Figure 58: U.K. Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 59: Incidences of Neurological Disorders in Germany, Million, 2018-2021
  • Figure 60: Germany Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 61: Incidences of Neurological Disorders in France, Million, 2018-2021
  • Figure 62: France Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 63: Incidences of Neurological Disorders in Rest-of-Europe, Million, 2018-2021
  • Figure 64: Rest-of-Europe Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 65: Asia Pacific Stereotactic Neuro-Navigation Market, Spinal Navigation Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 66: Asia Pacific Stereotactic Neuro-Navigation Market, Cranial Stereotactic Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 67: Asia Pacific Stereotactic Neuro-Navigation Market, $Million, 2023-2035
  • Figure 68: Incidences of Neurological Disorders in Japan, Million, 2018-2021
  • Figure 69: Japan Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 70: Incidences of Neurological Disorders in China, Million, 2018-2021
  • Figure 71: China Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 72: Incidences of Neurological Disorders in Rest-of-Asia-Pacific, Million, 2018-2021
  • Figure 73: Rest-of-Asia-Pacific Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 74: Rest-of-the-World Stereotactic Neuro-Navigation Market, Spinal Navigation Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 75: Rest-of-the-World Stereotactic Neuro-Navigation Market, Cranial Stereotactic Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 76: Rest-of-the-World Stereotactic Neuro-Navigation Market, $Million, 2023-2035
  • Figure 77: Strategic Initiatives, January 2017-May 2025
  • Figure 78: Data Triangulation
  • Figure 79: Top-Down and Bottom-Up Approach
  • Figure 80: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Competitive Landscape Snapshot
  • Table 3: Some of the Key Developments
  • Table 4: CPT Coding
  • Table 5: Inpatient Reimbursement
  • Table 6: Medical Devices Classification Medical Devices in Japan
  • Table 7: Regulatory Process in RoW
  • Table 8: Price of Stereotactic Neuro-Navigation System
  • Table 9: Drivers, Restraints, and Opportunities: Current and Future Impact Assessment
  • Table 10: Comparison between Various Navigation-Assisted Surgeries Over Conventional Surgeries
  • Table 11: Sources of Error in Navigated Surgery
  • Table 12: Cost of Acquisition of Key Neuro-Navigation Systems
  • Table 13: Stealth Station Navigation System, Average Selling Price, (in $), 2024
  • Table 14: Curve Navigation System, Average Price, (in $), 2024
  • Table 15: Q Guidance System, Average Pricing, (in $), 2024
  • Table 16: easyNav, Average Pricing, (in $), 2024
  • Table 17: 7D Surgical System, Average Pricing, (in $), 2024
  • Table 18: Xvision-Spine System, Average Pricing, (in $), 2024
  • Table 19: Caduceus S (AR), Average Pricing, (in $), 2024
  • Table 20: Global Stereotactic Neuro-Navigation System Market, Stereotactic Frame Units (by Type), $Million, 2023-2035
  • Table 21: Global Stereotactic Neuro-Navigation System Market (by Region), $Million, 2023-2035
  • Table 22: U.S. Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 23: Canada Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 24: U.K. Incidences of Neurological Disorders, By Disease Type, 2018-2021
  • Table 25: Germany Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 26: France Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 27: Rest-of-Europe Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 28: Japan Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 29: China Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 30: Rest-of-Asia-Pacific Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 31: Some of the Strategies and Development, January 2017-May 2025
  • Table 32: Global Stereotactic Neuro-Navigation System Market, Product Benchmarking (by Product)
  • Table 33: Market Share Analysis, 2024